Psilocybin cultivation, possession, transportation, and personal use by individuals 21 years of age or older authorized; protections established; public education and harm reduction programs established; Psychedelic Medicine Board established; criminal penalties provided; rulemaking authorized; civil actions authorized; and money appropriated.

What happened: A Minnesota bill that would authorize psilocybin cultivation, possession, transportation, and personal use for adults 21 and older, establish a Psychedelic Medicine Board, and create public education and harm reduction programs has been introduced and referred to the Health Finance and Policy Committee.

Why it matters: If enacted, the bill would create a new regulated market for psilocybin with licensing and testing requirements that could affect businesses and labs already operating in adjacent cannabis or psychedelic wellness sectors.

Affects: cultivators and retailers and labs and patients